Alejandro Ocampo Selected Research

Alejandro Ocampo Research Topics

2	Temporal Lobe Epilepsy 12/2020 - 01/2020
2	Status Epilepticus (Complex Partial Status Epilepticus) 12/2020 - 01/2020
2	Epilepsy (Aura) 12/2020 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2015 - 05/2010
2	Proteostasis Deficiencies 05/2013 - 01/2011
2	Huntington Disease (Huntington's Disease) 05/2010 - 10/2008
1	Seizures (Absence Seizure) 01/2020
1	Neoplasms (Cancer) 01/2019
1	Ulcer 01/2018
1	MELAS Syndrome (Syndrome, MELAS) 08/2015
1	Leigh Disease (Leigh's Disease) 08/2015
1	Werner Syndrome (Werner's Syndrome) 06/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2015
1	Neuropathy ataxia and retinitis pigmentosa 04/2015
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 04/2015
1	Muscular Dystrophies (Muscular Dystrophy) 10/2014
1	Wallerian Degeneration 05/2013

3	Pharmaceutical PreparationsIBA 12/2020 - 10/2014
3	polyglutamineIBA 05/2013 - 10/2008
2	Mitochondrial DNA (mtDNA)IBA 08/2015 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 05/2010
1	Kainic Acid (Kainate)IBA 12/2020
1	ElementsIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	NucleotidesIBA 08/2015
1	HeterochromatinIBA 06/2015
1	Transcription Activator-Like Effector NucleasesIBA 04/2015
1	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2013
1	SynucleinsIBA 05/2013
1	AtaxinsIBA 05/2013
1	nicotinic acid mononucleotide adenylyltransferase (nicotinate nucleotide adenylyltransferase)IBA 05/2013

2	Therapeutics 01/2019 - 01/2018
1	Transplantation 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2014